Skip to main content

Table 2 Cumulative incidence of depressive symptoms in relation to MetS and metabolic disorders with a median follow-up of 4.3 years

From: Metabolic syndrome associated with the onset of depressive symptoms among women but not men in rural Northeast China

  

Numbers

No. of Depressive incidents

Model one a

Model two b

Model three c

OR(95%CI)

P-value

OR(95%CI)

P-value

OR(95%CI)

P-value

Women

Mets (−)

717 (57.2)

27 (3.8)

1.00(reference)

0.032

1.00(reference)

0.036

1.00(reference)

0.045

MetS (+)

536 (42.8)

39 (7.3)*

1.77 (1.05,2.98)

1.76 (1.04,2.98)

1.82 (1.01,3.27)

Elevated WC (−)

575 (45.9)

25 (4.3)

1.00(reference)

0.306

1.00(reference)

0.338

1.00(reference)

0.42

Elevated WC(+)

678 (54.1)

41 (6.0)

1.31 (0.78,2.19)

1.29 (0.77,2.17)

1.31 (0.68,2.50)

Hypertriglyceridemia (−)

883 (70.5)

40 (4.5)

1.00(reference)

0.195

1.00(reference)

0.304

1.00(reference)

0.384

Hypertriglyceridemia (+)

370 (29.5)

26 (7.0)*

1.41 (0.84,2.37)

1.32 (0.78,2.24)

1.28 (0.74,2.21)

Low HDL-C (−)

788 (62.9)

39 (4.9)

1.00(reference)

0.573

1.00(reference)

0.576

1.00(reference)

0.574

Low HDL-C (+)

465 (37.1)

27 (5.8)

1.16 (0.70,1.92)

1.16 (0.69,1.94)

1.16 (0.69,1.97)

Hyperglycemia (−)

733 (58.5)

33 (4.5)

1.00(reference)

0.343

1.00(reference)

0.383

1.00(reference)

0.458

Hyperglycemia (+)

520 (41.5)

33 (6.3)

1.28 (0.77,2.12)

1.26 (0.75,2.12)

1.22 (0.72,2.08)

Elevated BP (−)

471 (37.6)

16 (3.4)

1.00(reference)

0.096

1.00(reference)

0.089

1.00(reference)

0.127

Elevated BP (+)

782 (62.4)

50 (6.4)*

1.66 (0.91,3.02)

1.69 (0.92,3.09)

1.62 (0.87,3.01)

Men

Mets (−)

1021 (66.2)

26 (2.5)

1.00(reference)

0.302

1.00(reference)

 

1.00(reference)

 

MetS (+)

522 (33.8)

18 (3.4)

1.38 (0.75,2.54)

1.46 (0.78,2.70)

0.234

1.84 (0.88,3.83)

0.104

Elevated WC (−)

1076 (69.7)

29 (2.7)

1.00(reference)

0.515

1.00(reference)

0.276

1.00(reference)

0.102

Elevated WC(+)

467 (30.3)

15 (3.2)

1.23 (0.65,2.33)

0.71 (0.38,1.32)

2.06 (0.87,4.90)

Hypertriglyceridemia (−)

1027 (66.6)

32 (3.2)

1.00(reference)

0.428

1.00(reference)

0.421

1.00(reference)

0.392

Hypertriglyceridemia (+)

516 (33.4)

12 (2.3)

0.76 (0.39,1.49)

0.76 (0.38,1.49)

0.73(.35,1.51)

Low HDL-C (−)

1310 (84.9)

36 (2.7)

1.00(reference)

0.503

1.00(reference)

0.545

1.00(reference)

0.436

Low HDL-C (+)

233 (15.1)

8 (3.4)

1.31 (0.60,2.86)

1.28 (0.58,2.84)

1.39 (0.61,3.20)

Hyperglycemia (−)

750 (48.6)

25 (3.3)

1.00(reference)

0.231

1.00(reference)

0.402

1.00(reference)

0.307

Hyperglycemia (+)

793 (51.4)

19 (2.4)

0.69 (0.38,1.27)

1.32 (0.69,2.52)

0.72 (0.39,1.35)

Elevated BP (−)

386 (25.0)

11 (2.8)

1.00(reference)

0.812

1.00(reference)

0.897

1.00(reference)

0.826

Elevated BP (+)

1157 (75.0)

33 (2.9)

0.92 (0.45,1.86)

0.95 (0.47,1.96)

0.92 (0.44,1.94)

  1. aadjusted for age; badjusted for age, current smoking and drinking, race, educational levels, income level, regular exercise, children number, chronic diseases (including heart disease, cerebral diseases, kidney diseases); cadjusted for age, current smoking and drinking, race, educational levels, income level, regular exercise, children number, chronic diseases (including heart disease, cerebral diseases, kidney diseases), BMI and eGFR